| CTRI Number |
CTRI/2024/07/070241 [Registered on: 09/07/2024] Trial Registered Prospectively |
| Last Modified On: |
02/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
PMS |
|
Type of Study
|
Medical Device |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
To evaluate the safety and performance of facial bone plates and time taken in bone union. |
|
Scientific Title of Study
|
A Prospective, Post Market Clinical Follow-up (PMCF) Study to Evaluate the Safety and Performance of
Craniomaxillofacial Plate System |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| CR_PMCF/P_03, Version: 1.0, Date: 05.01.2024 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Gursimrat Singh |
| Designation |
Director & Consultant |
| Affiliation |
Cheema Hospital and Trauma Center |
| Address |
Room no. 2, Ground Floor, Department of Orthopedics, Cheema Hospital and Trauma Center, Kichha Road, Bigbara, Rudrapur
Udham Singh Nagar UTTARANCHAL 263153 India |
| Phone |
9639069009 |
| Fax |
|
| Email |
drgscheema@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Mohd Aslam |
| Designation |
Clinical Research Manager |
| Affiliation |
Auxein Medical Pvt Ltd |
| Address |
First floor, Clinical Research Department,
Auxein Medical Pvt Ltd
Plot Number 168 â€169â€170, Phase IV, HSIIDC,
Industrial Estate, Kundli
Sonipat HARYANA 131028 India |
| Phone |
7419660141 |
| Fax |
|
| Email |
clinical2@auxeinmedical.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Mohd Aslam |
| Designation |
Clinical Research Manager |
| Affiliation |
Auxein Medical Pvt Ltd |
| Address |
First floor, Clinical Research Department,
Auxein Medical Pvt Ltd
Plot Number 168 â€169â€170, Phase IV, HSIIDC,
Industrial Estate, Kundli
Sonipat HARYANA 131028 India |
| Phone |
7419660141 |
| Fax |
|
| Email |
clinical2@auxeinmedical.com |
|
|
Source of Monetary or Material Support
|
| Auxein Medical Pvt Ltd
Plot Number 168 â€169â€170 Phase IV, HSIIDC,
Industrial Estate, Kundli, Sonepat Haryana 131028 |
|
|
Primary Sponsor
|
| Name |
Auxein Medical Pvt Ltd |
| Address |
Plot Number 168 â€169â€170 Phase IV, HSIIDC, Industrial Estate, Kundli, Sonepat Haryana |
| Type of Sponsor |
Other [Medical device manufacturer] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Gursimrat Singh |
Cheema Hospital and Trauma Center |
Room no. 2, Department of Orthopedics,
Kichha Road, Bigbara, Rudrapur, U.S Nagar, Uttarakhand -263153 India Udham Singh Nagar UTTARANCHAL |
9639069009
drgscheema@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: Q189||Congenital malformation of face and neck, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Craniomaxillocofacial (CMF) plates and screws for fixation of facial bone deformity and fractures |
CMF plates and screws will be used for fixation of facial bones. |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
1. Male or Female, aged 18 - 75 years.
2. Patients presenting emergency/OPD requiring fixation of CMF fracture. |
|
| ExclusionCriteria |
| Details |
1. Subjects with a disease entity or condition that could hinder bone healing
and create unacceptable risk of fixation failure or complications such as
known active cancer, neuromuscular disorder.
2. Subjects with metabolic bone disease.
3. Subject with inadequate tissue coverage of the operative site.
4. Subjects with substance abuse/alcoholics.
5. Subjects who are incarcerated or have pending incarceration.
6. Female participant who is pregnant or planning pregnancy during the
study.
7. Morbid obesity. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
1 Bone healing and union
2 Improvement in QOL |
6 week
3 month
6 month and 12 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Recording of AEs SAEs |
6 week
3 month
6 month and 12 month |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "20"
Final Enrollment numbers achieved (India)="20" |
|
Phase of Trial
|
Post Marketing Surveillance |
|
Date of First Enrollment (India)
|
15/07/2024 |
| Date of Study Completion (India) |
Date Missing |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Assessing the functional and aesthetic outcomes of craniomaxillofacial reconstruction is essential for evaluating the success of treatment interventions. Outcome measures, such as patient-reported outcomes, quality of life assessments, and objective functional evaluations, provide valuable insights into the effectiveness of various surgical approaches and techniques. Long-term follow-up is necessary to monitor for potential complications, such as implant failures, infections, or late sequelae, and address them promptly. Craniomaxillofacial trauma requires a comprehensive and multidisciplinary approach for evaluation, management, and reconstruction. By collaborating among various specialists, leveraging technological advancements, and emphasizing long-term follow-up, healthcare professionals can optimize patient outcomes and minimize complications in craniomaxillofacial trauma. Present post marketing clinical follow up study aims to evaluate the safety and performance of craniomaxillofacial plates and screws manufactured by Auxein Medical Pvt Ltd. |